The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.
Overview
- Phase
- Phase 4
- Intervention
- Exparel
- Conditions
- Postoperative Pain
- Sponsor
- Spectrum Health Hospitals
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Postoperative Pain Score
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients over the age of 18 years w
- •Elective laparoscopic colorectal resection.
Exclusion Criteria
- •Patients under 18 years.
- •Patients unable to provide informed consent
- •Patients undergoing emergency surgery.
- •Pregnant women
- •Severe liver or kidney disease (GFR 15-29 ml/min)
Arms & Interventions
TAP Block Experal
Patient who randomized to this arm, will be blinded, TAP block will be performed under ultrasound guidance, where 20-30 ml of Exparel will be injected in transversus abdominis plane, bilaterally.
Intervention: Exparel
TAP Block Experal
Patient who randomized to this arm, will be blinded, TAP block will be performed under ultrasound guidance, where 20-30 ml of Exparel will be injected in transversus abdominis plane, bilaterally.
Intervention: TAP Block
Outcomes
Primary Outcomes
Postoperative Pain Score
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 days
Patient will be evaluate for their post operative pain by nurses using visual analog scale from 0 to 10, zero means no pain, 10 is the worst pain can patient ever experience.
Secondary Outcomes
- Postoperative Narcotic Use(participants will be followed for the duration of hospital stay, an expected average of 4 days)